Certolizumab Pegol for the Treatment of Patients With Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials. J of Skin 2018, 2 (S1), S3. https://doi.org/10.25251/skin.2.supp.3.